These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 35066766)

  • 1. FOXM1 mediates GDF-15 dependent stemness and intrinsic drug resistance in breast cancer.
    Modi A; Purohit P; Roy D; Vishnoi JR; Pareek P; Elhence P; Singh P; Sharma S; Sharma P; Misra S
    Mol Biol Rep; 2022 Apr; 49(4):2877-2888. PubMed ID: 35066766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GALNT14 in association with GDF-15 promotes stemness and drug resistance through β-catenin signalling pathway in breast cancer.
    Gadwal A; Purohit P; Khokhar M; Vishnoi JR; Pareek P; Choudhary R; Elhence P; Banerjee M; Sharma P
    Mol Biol Rep; 2024 May; 51(1):691. PubMed ID: 38796671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GALNT6, GALNT14, and Gal-3 in association with GDF-15 promotes drug resistance and stemness of breast cancer
    Gadwal A; Purohit P; Khokhar M; Vishnoi JR; Pareek P; Choudhary R; Elhence P; Banerjee M; Sharma P
    Growth Factors; 2024 May; 42(2):84-100. PubMed ID: 38889447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrating bioinformatics and experimental models to investigate the mechanism of the chelidonine-induced mitotic catastrophe via the AKT/FOXO3/FOXM1 axis in breast cancer cells.
    Li H; Tang X; Sun Z; Qu Z; Zou X
    Biomol Biomed; 2024 May; 24(3):560-574. PubMed ID: 37976368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activin and Hepatocyte Growth Factor Promotes Colorectal Cancer Stemness and Metastasis through FOXM1/SOX2/CXCR4 Signaling.
    Peng H; Ye T; Deng L; Yang X; Li Q; Tong J; Guo J
    Gut Liver; 2024 May; 18(3):476-488. PubMed ID: 37458065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulation of FoxM1 by MnSOD Overexpression Contributes to Cancer Stem-Like Cell Characteristics in the Lung Cancer H460 Cell Line.
    Fu Z; Cao X; Yang Y; Song Z; Zhang J; Wang Z
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818789635. PubMed ID: 30111255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dinaciclib inhibits the stemness of two subtypes of human breast cancer cells by targeting the FoxM1 and Hedgehog signaling pathway.
    Tsao AN; Chuang YS; Lin YC; Su Y; Chao TC
    Oncol Rep; 2022 May; 47(5):. PubMed ID: 35417031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FOXM1 facilitates breast cancer cell stemness and migration in YAP1-dependent manner.
    Sun HL; Men JR; Liu HY; Liu MY; Zhang HS
    Arch Biochem Biophys; 2020 May; 685():108349. PubMed ID: 32209309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The FOXM1-ABCC5 axis contributes to paclitaxel resistance in nasopharyngeal carcinoma cells.
    Hou Y; Zhu Q; Li Z; Peng Y; Yu X; Yuan B; Liu Y; Liu Y; Yin L; Peng Y; Jiang Z; Li J; Xie B; Duan Y; Tan G; Gulina K; Gong Z; Sun L; Fan X; Li X
    Cell Death Dis; 2017 Mar; 8(3):e2659. PubMed ID: 28277541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FOXM1 recruits nuclear Aurora kinase A to participate in a positive feedback loop essential for the self-renewal of breast cancer stem cells.
    Yang N; Wang C; Wang Z; Zona S; Lin SX; Wang X; Yan M; Zheng FM; Li SS; Xu B; Bella L; Yong JS; Lam EW; Liu Q
    Oncogene; 2017 Jun; 36(24):3428-3440. PubMed ID: 28114286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The forkhead transcription factor FOXM1 promotes endocrine resistance and invasiveness in estrogen receptor-positive breast cancer by expansion of stem-like cancer cells.
    Bergamaschi A; Madak-Erdogan Z; Kim YJ; Choi YL; Lu H; Katzenellenbogen BS
    Breast Cancer Res; 2014 Sep; 16(5):436. PubMed ID: 25213081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FoxM1 Promotes Stemness and Radio-Resistance of Glioblastoma by Regulating the Master Stem Cell Regulator Sox2.
    Lee Y; Kim KH; Kim DG; Cho HJ; Kim Y; Rheey J; Shin K; Seo YJ; Choi YS; Lee JI; Lee J; Joo KM; Nam DH
    PLoS One; 2015; 10(10):e0137703. PubMed ID: 26444992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FOXM1 Promotes Drug Resistance in Cervical Cancer Cells by Regulating ABCC5 Gene Transcription.
    Hou Y; Dong Z; Zhong W; Yin L; Li X; Kuerban G; Huang H
    Biomed Res Int; 2022; 2022():3032590. PubMed ID: 35141332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. WHSC1 promotes wnt/β-catenin signaling in a FoxM1-dependent manner facilitating proliferation, invasion and epithelial-mesenchymal transition in breast cancer.
    Zhang J; Lu J; Chen Y; Li H; Lin L
    J Recept Signal Transduct Res; 2020 Oct; 40(5):410-418. PubMed ID: 32314642
    [No Abstract]   [Full Text] [Related]  

  • 15. AKT/FOXM1/STMN1 signaling pathway activation by SMC1A promotes tumor growth in breast cancer.
    Li K; Dai P; Li J; Liu L; Cheng S; Fang Q; Wu B
    J Gene Med; 2024 Jan; 26(1):e3661. PubMed ID: 38282144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Napabucasin Attenuates Resistance of Breast Cancer Cells to Tamoxifen by Reducing Stem Cell-Like Properties.
    Liu X; Huang J; Xie Y; Zhou Y; Wang R; Lou J
    Med Sci Monit; 2019 Nov; 25():8905-8912. PubMed ID: 31760402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resistin potentiates chemoresistance and stemness of breast cancer cells: Implications for racially disparate therapeutic outcomes.
    Deshmukh SK; Srivastava SK; Zubair H; Bhardwaj A; Tyagi N; Al-Ghadhban A; Singh AP; Dyess DL; Carter JE; Singh S
    Cancer Lett; 2017 Jun; 396():21-29. PubMed ID: 28302531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HOXD3 Plays a Critical Role in Breast Cancer Stemness and Drug Resistance.
    Zhang Y; Zhang Q; Cao Z; Huang Y; Cheng S; Pang D
    Cell Physiol Biochem; 2018; 46(4):1737-1747. PubMed ID: 29698974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistance to FOXM1 inhibitors in breast cancer is accompanied by impeding ferroptosis and apoptotic cell death.
    Kumar S; Ziegler Y; Plotner BN; Flatt KM; Kim SH; Katzenellenbogen JA; Katzenellenbogen BS
    Breast Cancer Res Treat; 2024 Nov; 208(2):307-320. PubMed ID: 38980505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apigenin, a Partial Antagonist of the Estrogen Receptor (ER), Inhibits ER-Positive Breast Cancer Cell Proliferation through Akt/FOXM1 Signaling.
    Pham TH; Page YL; Percevault F; Ferrière F; Flouriot G; Pakdel F
    Int J Mol Sci; 2021 Jan; 22(1):. PubMed ID: 33466512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.